RE:RE:RE:RE:Upcoming vote?baggerx99 wrote: Without replaying, MG did say he and institutions were happy with the share structure and thta an RS was not at play at this point......IMO, MG is hoping the sp to grow organically....
Iamapothead wrote: Agreed. R/S usually screw the shareholders who got in early when the company needed money the most.
It wouldn't make sense to R/S at this price. It would make sense to possibly R/S at $2.00 +. At most the company would only want a 2:1 R/S at that price. This would jump the share price to an acceptable level for the TSX and only cut the outstanding shares in half which would still provide an acceptable number of shares for liquidity. If you reduce the shares too much than you kill the liquidity of a stock. Institutions love liquidity which is why the current share structure is acceptable as is.
In the end, no R/S should be necessary if this stock begins to reflect it's true value in the share price. And than if you give the stock a little extra valuation like all these other stocks are getting, the stock would hit an acceptable price for the TSX too. DM currently has a positive EPS of $0.03. Again, find me another micro/small cap stock with a positive EPS. DM exceeds these stocks by 10, 15, 20 or more cents for and EPS. Yet their share price far exceeds that of DM and that is taking into acocount the shares outstanding.
I agree this stock can move up organically with their current revenues, AI contracts, Medi-Call and so much more. The talk of a R/S is completely out of sync and premature with the current revenue and growth of this company until the stock starts to hit prices nearing $2.00 or more.